Table 2.

Study population characteristics (n = 110).

Helicobacter pylori therapy naïve patients (n = 110) Overall resistance rate n = 74/110 (67.3%)
No atrophy (OLGA Stage 0) n = 46
Sex	Males n = 14
Age (y.o ± SD)	47.7 ± 11.8
Resistance rate (overall)	30 (65.2%)
Mild atrophy (OLGA Stage I–II) n = 40
Sex	Males n = 9
Age (y.o ± SD)	48.2 ± 13.8 years
Resistance rate (overall)	28 (70.0%)
Moderate/severe atrophic gastritis (OLGA Stage III–IV) n = 24
Sex	Males n = 9
Age (y.o ± SD)	54.9 ± 14.0 years
Resistance rate (overall)	16 (66.7%)

y.o: years old; SD: standard deviation.